This document announces a CME dinner meeting on advances in managing atrial fibrillation, focusing on special populations. The meeting will be held on June 25, 2010 in Washington, DC. It will provide up to 1.5 credits and cover diagnosing and treating AF, considering new options and data. Speakers will discuss AF's impact on health and quality of life, evaluating treatment approaches, and optimizing outcomes. They will also address managing AF in elderly, women, and minorities. The goal is improving care for AF, a common arrhythmia whose burden is growing as the population ages.

1. The Association of Black Cardiologists, Inc. is pleased to invite you to
A LIVE INTERACTIVE CME DINNER MEETING
FRIDAY, JUNE 25, 2010
The Newseum
555 Pennsylvania Avenue NW
Washington, DC
ADVANCES IN THE MANAGEMENT OF ATRIAL FIBRILLATION:
A FOCUS ON SPECIAL POPULATIONS
7:00 – 8:00 PM HOSTED BY
Registration/Dinner Reception Boisey O. Barnes, MD, FACC
MODERATED BY
8:00 – 9:30 PM
Program Keith C. Ferdinand, MD, FACC, FAHA
CO-CHAIRS
9:30 PM John M. Fontaine, MD, MBA, FACC
Program Adjourns Kevin L. Thomas, MD, FACC
FACULTY
T. David Gbadebo, MD, FACC
Supported by an educational Sponsored by Produced by
grant from Sanofi-Aventis

2. STATEMENT OF NEED
With a prevalence of nearly 1% among US adults, atrial fibrillation
(AF) is the most common type of cardiac arrhythmia necessitating
medical care. Its consequences are profound; AF approximately
doubles the rate of death. Because prevalence increases with age,
AF hospitalizations have increased by 66% over the last 2 decades.
By 2025 and 2050, it is projected that more than 3.8 and 5.6 million US patients
respectively will be hospitalized for AF, indicating a substantially increased risk
of stroke, congestive heart failure, and death, and exponentially worsening
an already substantial public health burden. A number of studies have also
demonstrated the deleterious impact of AF on quality of life, with some authors
underscoring the negative impact of various therapies for AF. Other challenges
involve identification of AF, patient risk stratification, the relative risks/benefits
of early intervention, and a key debate in optimal therapeutic approach.
Therapeutic questions may be intensified in the care of special populations who
may require different management strategies, especially in light of recent findings.
Against this backdrop, the availability of new treatment options creates yet
another imperative for timely and effective medical education.
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
• Discuss the impact of paroxysmal/persistent AF and/or atrial flutter (AFL) on
individual cardiovascular health and quality of life as well as the overall public
health burden of these disorders
• Maximize opportunities for diagnosis and treatment of AF and/or AFL,
including recognition of prognostic factors of greatest significance
• Evaluate whether some treatments may prevent electrical, contractile, and/or
structural changes associated with disease progression
• Analyze the benefits and outcomes of rhythm-control vs rate-control therapies,
and consider the newest therapeutic options and latest data when making
evidence-based treatment decisions
• Recognize contraindications to various treatments as well as considerations
for the treatment of special populations, including the elderly, women, and
racial/ethnic minorities
• Optimize patient outcomes through a better understanding of the value of
primary and secondary prevention strategies for AF/AFL, along with a better
definition of treatment success

3. CME INFORMATION
INTENDED AUDIENCE
This activity is intended for cardiologists and electrophysiologists as well as other health care
providers such as hospital-based clinicians, primary care physicians, physician assistants, and
nurse practitioners whose clinical responsibilities require competence in the diagnosis and
treatment of AF/AFL.
No prerequisites are required to participate in this activity.
ACCREDITATION
The Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION
The Association of Black Cardiologists, Inc. designates this educational activity for a maximum
of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate
with the extent of their participation in the activity.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The Association of Black Cardiologists, Inc. gratefully acknowledges sanofi-aventis for the
educational grant in support of this activity.
DISCLOSURE INFORMATION
The Association of Black Cardiologists, Inc. (ABC) endorses the Guidelines of the American
Medical Association and the Standards of the Accreditation Council for Continuing Medical
Education. Therefore, faculty or anyone involved with the presentation content for a CME
activity must disclose to participants the presence of any relationships with commercial
companies (health care-related). The Association of Black Cardiologists, Inc. ensures that all
faculty and staff involved in the planning, development, and implementation of the ABC activity
will disclose all potential conflicts of interest and resolve them prior to the CME activity.
Complete information will be provided to participants at the start of the educational activity.
PROGRAM FEATURES
• Faculty introductions provided by your local host
• Expert Input - interaction with 3 national clinical leaders in cardiovascular medicine
• Evidence-based educational format featuring the latest data on disease impact, diagnosis,
prognosis, treatment, prevention, and focusing on special populations
• Participant-Centered Learning: in addition to reviewing a selection of cases, participants
will be queried at key points throughout the program to identify individual practice-based
challenges and indicate consensus with recommended solutions
• Active Learning: an audience-response system will be utilized for participants to respond
to multiple-choice questions and receive immediate feedback throughout the program

4. HOSTED BY
Boisey O. Barnes, MD, FACC
Founding Member
The Association of Black Cardiologists, Inc.
Washington, DC
MODERATED BY
Keith C. Ferdinand, MD, FACC, FAHA
Chief Science Officer
The Association of Black Cardiologists, Inc.
Clinical Professor, Cardiology Division
Emory University
Atlanta, Georgia
CO-CHAIRS
John M. Fontaine, MD, MBA, FACC
Professor of Medicine
Director, Arrhythmia Services and
Cardiology Fellowship Training Program
Drexel University College of Medicine
Philadelphia, Pennsylvania
Kevin L. Thomas, MD, FACC
Assistant Professor of Medicine
Clinical Cardiac Electrophysiology
Division of Cardiovascular Disease
Duke University Medical Center
Durham, North Carolina
FACULTY
T. David Gbadebo, MD, FACC
Chair of Electrophysiology Committee
The Association of Black Cardiologists, Inc.
Director of Electrophysiology
Cardiovascular Care Center
Chattanooga, Tennessee

5. You are invited to
A LIVE INTERACTIVE CME DINNER MEETING
Advances in the Management of Atrial Fibrillation:
A Focus on Special Populations
FRIDAY, JUNE 25, 2010
REGISTRATION INFORMATION
3 WAYS TO REGISTER
ONLINE at www.abcafib.com/dinnerDC
FAX your completed form to 800-819-2292
CALL our registration line at 800-325-9042
PLEASE PRINT CLEARLY (ALL FIELDS ARE REQUIRED FOR YOUR REGISTRATION)
Last Name First Name Middle Initial
Degree/License
Specialty
Affiliation
Street Address/PO Box Suite
City State ZIP
Day Phone Evening Phone
Fax Number* E-mail Address*
Please notify me of future ABC continuing education initiatives
*You must provide a fax number or E-mail address in order to receive confirmation materials.
Confirmation materials will be sent via fax or E-mail within 1 week of receipt of your registration.

6. Advances in the Management
of Atrial Fibrillation:
A Focus on Special Populations
Darwin Academy
Park 80 West
Plaza II, Suite 200
Saddle Brook, NJ 07663-5836
A LIVE INTERACTIVE CME DINNER MEETING